Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
May 19, 2022 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., May 19, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has received National Medical Products...
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
May 13, 2022 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., May 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the full U.S. commercial launch of its UroLift® 2...
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
April 11, 2022 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the launch of the UroLift System in Japan for...
Teleflex Receives Reimbursement Approval for the UroLift® System in Japan
December 13, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the company has received reimbursement approval from the Central Social Insurance Medical Council...
The UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives
October 29, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that the UroLift® System was honored by DTC Perspectives with a Bronze Award in the “Best New Branded...
Teleflex Reports Third Quarter 2021 Results and Full Year Outlook
October 28, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter...
Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
September 09, 2021 06:30 ET
|
Teleflex Incorporated
New real-world data findings along with new product evolutions demonstrate why the UroLift® System is the right solution for most BPH patients WAYNE, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) --...
New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms
August 30, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of clinical data for the UroLift® System in the peer-reviewed journal Prostate Cancer...
Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System
July 09, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., July 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that the largest U.S. healthcare claims and utilization analysis for benign prostatic hyperplasia (BPH)...
Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
July 06, 2021 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., July 06, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that new data from real-world clinical studies of the UroLift® System for men with benign prostatic...